Key result
Travel to Beijing is linked to a ~101% increase in CRP and systemic inflammation.
Why the study?
Preventing chronic cardiovascular diseases caused by air pollution relies on detecting early effects of pollutants, but sensitive biomarkers in humans are lacking.
Does traveling from a less-polluted to a more-polluted city increase systemic pro-oxidative and proinflammatory biomarkers in healthy adults?
Observational (n=26)
Yes
Does traveling from a less-polluted to a more-polluted city increase systemic pro-oxidative and proinflammatory biomarkers in healthy adults?
Traveling to a highly polluted city induces reversible systemic pro-oxidative and proinflammatory effects, highlighting potential early biomarkers for cardiovascular risk from air pollution.
Answers are grounded in this paper and cite their sources.
Travel to polluted cities may transiently elevate CV risk biomarkers; hypothesis-generating for pollution effects, needing prospective validation before practice change.
Background: Exposure to air pollution increases cardiovascular morbidity and mortality. Preventing chronic cardiovascular diseases caused by air pollution relies on detecting the early effects of pollutants on the risk of cardiovascular disease development, which is limited by the lack of sensitive biomarkers. We have previously identified promising biomarkers in experimental animals but comparable evidence in humans is lacking. Methods: Air pollution is substantially worse in Beijing than in Los Angeles. We collected urine and blood samples from 26 nonsmoking, healthy adult residents of Los Angeles (mean age, 23.8 years; 14 women) before, during, and after spending 10 weeks in Beijing during the summers of 2014 and 2015. We assessed a panel of circulating biomarkers indicative of lipid peroxidation and inflammation. Personal exposure to polycyclic aromatic hydrocarbons (PAHs), a group of combustion-originated air pollutants, was assessed by urinary PAH metabolite levels. Results: Urinary concentrations of 4 PAH metabolites were 176% (95% CI, 103% to 276%) to 800% (95% CI, 509% to 1780%) greater in Beijing than in Los Angeles. Concentrations of 6 lipid peroxidation biomarkers were also increased in Beijing, among which 5-, 12-, and 15-hydroxyeicosatetraenoic acid and 9- and 13-hydroxyoctadecadienoic acid levels reached statistical significance (false discovery rate <5%), but not 8-isoprostane (20.8%; 95% CI, −5.0% to 53.6%). The antioxidative activities of paraoxonase (−9.8%; 95% CI, −14.0% to −5.3%) and arylesterase (−14.5%; 95% CI, −22.3% to −5.8%) were lower and proinflammatory C-reactive protein (101%; 95% CI, 3.3% to 291%) and fibrinogen (48.3%; 95% CI, 4.9% to 110%) concentrations were higher in Beijing. Changes in all these biomarkers were reversed, at least partially, after study participants returned to Los Angeles. Changes in most outcomes were associated with urinary PAH metabolites ( P <0.05). Conclusions: Traveling from a less-polluted to a more-polluted city induces systemic pro-oxidative and proinflammatory effects. Changes in the levels of 5-, 12-, and 15-hydroxyeicosatetraenoic acid and 9- and 13-hydroxyoctadecadienoic acid as well as paraoxonase and arylesterase activities in the blood, in association with exposures to PAH metabolites, might have important implications in preventive medicine as indicators of increased cardiovascular risk caused by air pollution exposure.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2019) conducted an observational in Healthy (n=26). Travel to a highly polluted city (Beijing) vs. Baseline in a less-polluted city (Los Angeles) was evaluated on Panel of circulating biomarkers indicative of lipid peroxidation and inflammation, and urinary PAH metabolites (p=<0.05). Traveling from Los Angeles to Beijing for 10 weeks induced systemic pro-oxidative and proinflammatory effects, including a 101% increase in C-reactive protein (95% CI, 3.3-291%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: